ERBB2 and neoplasm: In the multivariate analysis, tumor multiplicity (OR: 1.768, CI 1.209–2.586, p = 0.003) and ER positivity (OR: 2.580, CI 1.371–4.854, p = 0.003) were proven to be independent predictive factors for HER2-zero to low conversion (Table 5).